Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
medicare
national
5
×
national blog main
national top stories
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
president trump
alex azar
alexion pharmaceuticals
cancer
cvs health
department of health and human services
donald trump
drug prices
investing
medicaid
novartis
pfizer
What
drug
5
×
plan
5
×
prices
prescription
awaited
bio
blueprint
details
house
long
lower
roundup
trump
administration
advantages
afternoon
alzheimer’s
anathema
announced
anticipated
bar
biopharma
brings
cheaper
companies
cost
cut
democrat
different
drugs
elements
expect
fail
foreign
gamble
gene
increases
latest
leaked
look
Language
unset
Current search:
drug
×
national
×
plan
×
@xconomy.com
4 years ago
After First Look at House Drug Plan, Stocks Rise Slightly
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Trump Plan Ties Medicare Drug Prices to Cheaper Foreign Ones
@xconomy.com
5 years ago
Trump Pledges Lower Drug Prices, But Blueprint Is Short on Details